Global Dermatology OTC Medications Market Research Report 2023(Status and Outlook)
Report Overview
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
The Global Dermatology OTC Medications Market Size was estimated at USD 12410.00 million in 2022 and is projected to reach USD 15576.65 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Dermatology OTC Medications market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dermatology OTC Medications Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dermatology OTC Medications market in any manner.
Global Dermatology OTC Medications Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Market Segmentation (by Type)
External Use
Oral
Market Segmentation (by Application)
Law Enforcement
Home Security
Car Security
Consumer Electronics
Sports Enthusiasts
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Dermatology OTC Medications Market
Overview of the regional outlook of the Dermatology OTC Medications Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Dermatology OTC Medications
- 1.2 Key Market Segments
- 1.2.1 Dermatology OTC Medications Segment by Type
- 1.2.2 Dermatology OTC Medications Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Dermatology OTC Medications Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Dermatology OTC Medications Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Dermatology OTC Medications Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Dermatology OTC Medications Market Competitive Landscape
- 3.1 Global Dermatology OTC Medications Sales by Manufacturers (2018-2023)
- 3.2 Global Dermatology OTC Medications Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Dermatology OTC Medications Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Dermatology OTC Medications Sales Sites, Area Served, Product Type
- 3.6 Dermatology OTC Medications Market Competitive Situation and Trends
- 3.6.1 Dermatology OTC Medications Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Dermatology OTC Medications Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Dermatology OTC Medications Industry Chain Analysis
- 4.1 Dermatology OTC Medications Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Dermatology OTC Medications Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Dermatology OTC Medications Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Dermatology OTC Medications Sales Market Share by Type (2018-2023)
- 6.3 Global Dermatology OTC Medications Market Size Market Share by Type (2018-2023)
- 6.4 Global Dermatology OTC Medications Price by Type (2018-2023)
- 7 Dermatology OTC Medications Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Dermatology OTC Medications Market Sales by Application (2018-2023)
- 7.3 Global Dermatology OTC Medications Market Size (M USD) by Application (2018-2023)
- 7.4 Global Dermatology OTC Medications Sales Growth Rate by Application (2018-2023)
- 8 Dermatology OTC Medications Market Segmentation by Region
- 8.1 Global Dermatology OTC Medications Sales by Region
- 8.1.1 Global Dermatology OTC Medications Sales by Region
- 8.1.2 Global Dermatology OTC Medications Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Dermatology OTC Medications Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Dermatology OTC Medications Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Dermatology OTC Medications Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Dermatology OTC Medications Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Dermatology OTC Medications Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Bayer
- 9.1.1 Bayer Dermatology OTC Medications Basic Information
- 9.1.2 Bayer Dermatology OTC Medications Product Overview
- 9.1.3 Bayer Dermatology OTC Medications Product Market Performance
- 9.1.4 Bayer Business Overview
- 9.1.5 Bayer Dermatology OTC Medications SWOT Analysis
- 9.1.6 Bayer Recent Developments
- 9.2 GSK
- 9.2.1 GSK Dermatology OTC Medications Basic Information
- 9.2.2 GSK Dermatology OTC Medications Product Overview
- 9.2.3 GSK Dermatology OTC Medications Product Market Performance
- 9.2.4 GSK Business Overview
- 9.2.5 GSK Dermatology OTC Medications SWOT Analysis
- 9.2.6 GSK Recent Developments
- 9.3 Teva
- 9.3.1 Teva Dermatology OTC Medications Basic Information
- 9.3.2 Teva Dermatology OTC Medications Product Overview
- 9.3.3 Teva Dermatology OTC Medications Product Market Performance
- 9.3.4 Teva Business Overview
- 9.3.5 Teva Dermatology OTC Medications SWOT Analysis
- 9.3.6 Teva Recent Developments
- 9.4 Johnson andamp; Johnson
- 9.4.1 Johnson andamp; Johnson Dermatology OTC Medications Basic Information
- 9.4.2 Johnson andamp; Johnson Dermatology OTC Medications Product Overview
- 9.4.3 Johnson andamp; Johnson Dermatology OTC Medications Product Market Performance
- 9.4.4 Johnson andamp; Johnson Business Overview
- 9.4.5 Johnson andamp; Johnson Dermatology OTC Medications SWOT Analysis
- 9.4.6 Johnson andamp; Johnson Recent Developments
- 9.5 Novartis
- 9.5.1 Novartis Dermatology OTC Medications Basic Information
- 9.5.2 Novartis Dermatology OTC Medications Product Overview
- 9.5.3 Novartis Dermatology OTC Medications Product Market Performance
- 9.5.4 Novartis Business Overview
- 9.5.5 Novartis Dermatology OTC Medications SWOT Analysis
- 9.5.6 Novartis Recent Developments
- 9.6 Mylan
- 9.6.1 Mylan Dermatology OTC Medications Basic Information
- 9.6.2 Mylan Dermatology OTC Medications Product Overview
- 9.6.3 Mylan Dermatology OTC Medications Product Market Performance
- 9.6.4 Mylan Business Overview
- 9.6.5 Mylan Recent Developments
- 9.7 Sun Pharmaceutical
- 9.7.1 Sun Pharmaceutical Dermatology OTC Medications Basic Information
- 9.7.2 Sun Pharmaceutical Dermatology OTC Medications Product Overview
- 9.7.3 Sun Pharmaceutical Dermatology OTC Medications Product Market Performance
- 9.7.4 Sun Pharmaceutical Business Overview
- 9.7.5 Sun Pharmaceutical Recent Developments
- 9.8 Aurobindo
- 9.8.1 Aurobindo Dermatology OTC Medications Basic Information
- 9.8.2 Aurobindo Dermatology OTC Medications Product Overview
- 9.8.3 Aurobindo Dermatology OTC Medications Product Market Performance
- 9.8.4 Aurobindo Business Overview
- 9.8.5 Aurobindo Recent Developments
- 9.9 Galderma
- 9.9.1 Galderma Dermatology OTC Medications Basic Information
- 9.9.2 Galderma Dermatology OTC Medications Product Overview
- 9.9.3 Galderma Dermatology OTC Medications Product Market Performance
- 9.9.4 Galderma Business Overview
- 9.9.5 Galderma Recent Developments
- 9.10 CR SANJIU
- 9.10.1 CR SANJIU Dermatology OTC Medications Basic Information
- 9.10.2 CR SANJIU Dermatology OTC Medications Product Overview
- 9.10.3 CR SANJIU Dermatology OTC Medications Product Market Performance
- 9.10.4 CR SANJIU Business Overview
- 9.10.5 CR SANJIU Recent Developments
- 9.11 Dr. Reddy's
- 9.11.1 Dr. Reddy's Dermatology OTC Medications Basic Information
- 9.11.2 Dr. Reddy's Dermatology OTC Medications Product Overview
- 9.11.3 Dr. Reddy's Dermatology OTC Medications Product Market Performance
- 9.11.4 Dr. Reddy's Business Overview
- 9.11.5 Dr. Reddy's Recent Developments
- 9.12 Lupin
- 9.12.1 Lupin Dermatology OTC Medications Basic Information
- 9.12.2 Lupin Dermatology OTC Medications Product Overview
- 9.12.3 Lupin Dermatology OTC Medications Product Market Performance
- 9.12.4 Lupin Business Overview
- 9.12.5 Lupin Recent Developments
- 9.13 Bausch Health
- 9.13.1 Bausch Health Dermatology OTC Medications Basic Information
- 9.13.2 Bausch Health Dermatology OTC Medications Product Overview
- 9.13.3 Bausch Health Dermatology OTC Medications Product Market Performance
- 9.13.4 Bausch Health Business Overview
- 9.13.5 Bausch Health Recent Developments
- 9.14 Cipla
- 9.14.1 Cipla Dermatology OTC Medications Basic Information
- 9.14.2 Cipla Dermatology OTC Medications Product Overview
- 9.14.3 Cipla Dermatology OTC Medications Product Market Performance
- 9.14.4 Cipla Business Overview
- 9.14.5 Cipla Recent Developments
- 9.15 Qilu Pharmaceutical
- 9.15.1 Qilu Pharmaceutical Dermatology OTC Medications Basic Information
- 9.15.2 Qilu Pharmaceutical Dermatology OTC Medications Product Overview
- 9.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product Market Performance
- 9.15.4 Qilu Pharmaceutical Business Overview
- 9.15.5 Qilu Pharmaceutical Recent Developments
- 9.16 Almirall
- 9.16.1 Almirall Dermatology OTC Medications Basic Information
- 9.16.2 Almirall Dermatology OTC Medications Product Overview
- 9.16.3 Almirall Dermatology OTC Medications Product Market Performance
- 9.16.4 Almirall Business Overview
- 9.16.5 Almirall Recent Developments
- 9.17 Lingrui
- 9.17.1 Lingrui Dermatology OTC Medications Basic Information
- 9.17.2 Lingrui Dermatology OTC Medications Product Overview
- 9.17.3 Lingrui Dermatology OTC Medications Product Market Performance
- 9.17.4 Lingrui Business Overview
- 9.17.5 Lingrui Recent Developments
- 10 Dermatology OTC Medications Market Forecast by Region
- 10.1 Global Dermatology OTC Medications Market Size Forecast
- 10.2 Global Dermatology OTC Medications Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Dermatology OTC Medications Market Size Forecast by Country
- 10.2.3 Asia Pacific Dermatology OTC Medications Market Size Forecast by Region
- 10.2.4 South America Dermatology OTC Medications Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Dermatology OTC Medications by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Dermatology OTC Medications Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Dermatology OTC Medications by Type (2024-2029)
- 11.1.2 Global Dermatology OTC Medications Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Dermatology OTC Medications by Type (2024-2029)
- 11.2 Global Dermatology OTC Medications Market Forecast by Application (2024-2029)
- 11.2.1 Global Dermatology OTC Medications Sales (K MT) Forecast by Application
- 11.2.2 Global Dermatology OTC Medications Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook